Cboe US - Nasdaq Real Time Price USD

Franklin Genomic Advancements ETF (HELX)

25.63
-0.59
(-2.23%)
As of May 14 at 2:15:36 PM EDT. Market Open.
Loading Chart for HELX
  • Previous Close 26.22
  • Open 25.61
  • Bid 25.75 x 1400
  • Ask 25.86 x 800
  • Day's Range 25.61 - 25.71
  • 52 Week Range 23.74 - 33.98
  • Volume 33
  • Avg. Volume 2,200
  • Net Assets 10.89M
  • NAV 25.63
  • PE Ratio (TTM) 30.38
  • Yield 0.00%
  • YTD Daily Total Return -11.15%
  • Beta (5Y Monthly) 1.10
  • Expense Ratio (net) 0.50%

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Franklin Templeton Investments

Fund Family

Health

Fund Category

10.89M

Net Assets

2020-02-25

Inception Date

Performance Overview: HELX

View More

Trailing returns as of 5/14/2025. Category is Health.

YTD Return

HELX
11.15%
Category
2.06%
 

1-Year Return

HELX
19.00%
Category
0.80%
 

3-Year Return

HELX
6.92%
Category
1.71%
 

People Also Watch

Holdings: HELX

View More

Sector Weightings

SectorHELX
Healthcare   94.38%
Technology   2.33%
Real Estate   0.43%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: HELX

View More

Research Reports: HELX

View More

Related Tickers